COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review
Journal article
Galgut O. et al, (2024), Vaccine: X, 20
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection.
Journal article
Jindal J. et al, (2024), Metabolism
Using matrix assisted laser desorption ionisation mass spectrometry combined with machine learning for vaccine authenticity screening.
Journal article
Clarke R. et al, (2024), NPJ Vaccines, 9
Dysregulated immunologic landscape of early host response in melioidosis.
Journal article
Rongkard P. et al, (2024), JCI Insight
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Journal article
Duyvesteyn HME. et al, (2024), Structure
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
Journal article
Suwarti S. et al, (2024), BMC Infect Dis, 24
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.
Journal article
Thanh TT. et al, (2024), Int J Infect Dis
Implications of suboptimal measles immunity in UK health-care workers.
Journal article
Ho A. et al, (2024), Lancet, 404, 23 - 24
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Journal article
Lim YJ. et al, (2024), Br J Haematol
Diabetes and risk of hospitalisation due to infection in northeastern Thailand: Retrospective cohort study using population-based healthcare service data.
Journal article
Peerawaranun P. et al, (2024), Diabet Med
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Journal article
Liu C. et al, (2024), Cell Rep Med, 5
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
Journal article
GBD 2021 Demographics Collaborators None., (2024), Lancet, 403, 1989 - 2056
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Journal article
Goodyear CS. et al, (2024), Lancet Rheumatol
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
Journal article
Jackson S. et al, (2024), Lancet Microbe
Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.
Journal article
Ali M. et al, (2024), Clin Exp Immunol
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Journal article
Liu C. et al, (2024), Nat Commun, 15
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
Journal article
IHME Pathogen Core Group None., (2024), Lancet Infect Dis
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Journal article
Zhou D. et al, (2024), Nat Commun, 15
Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains.
Journal article
Bharucha T. et al, (2024), Vaccine, 42, 1506 - 1511